• Nie Znaleziono Wyników

The Voice of the Editor-in-Chief


Academic year: 2022

Share "The Voice of the Editor-in-Chief"

Pokaż więcej ( Stron)

Pełen tekst



The Voice of the Editor-in-Chief

Dear Colleagues,

The beginning of the new year is a good moment to sum up the past one. It should be noted that it is a year since the first issue of the Clinical Diabetology was published completely in English. This was a year of intensive work, and during that time we received from you numerous manuscripts covering important topics, out of which we chose those that we found most interesting and valuable from both purely scien- tific and practical point of view. We would like to thank you for submitting so many papers and we are looking forward to more. The success of the Clinical Diabetology is mainly your merit. Our main intention is to fulfil the expectations of our Readers, mainly in terms of the practical aspect of published articles, so we are open to any comments and suggestions.

Another issue that is extremely important from the perspective of everyday care of diabetes patients is issuing the “Guidelines on the management of diabetic patients” prepared annually for 12 years by the Guideline Writing Group of the Polish Diabetes Association. The Guidelines for 2017, like last year, include modifications of many chapters. This year, experts repeatedly refer to the recommendations of other diabetes associations. In accordance with other diabetic organizations (the American Diabetes Association — ADA, the National Institute for Health and Care Excellence — NICE), glycaemic goals has been liberalized for women with diabetes who plan to become pregnant, and following the guidelines of the European Society of Cardiology (ESC) the re- commendations for treatment of dyslipidaemia in diabetic patients have been modified. These changes

are primarily intended to increase the chance for the implementation of the guidelines in clinical practice.

In addition, very important change in this year’s Gu- idelines is that for the first time some sections include references to the EBM (evidence based medicine) indicating the level of scientific evidence, which is modelled on the ADA guidelines. A novelty in the cur- rent Guidelines is also adding a chapter including tips for some specific situations in patients with diabetes, such as shift work, travelling across time-zones or glucocorticoid therapy, which can also be very useful from the point of view of the practitioner. As we all know, from several years intensive studies have been conducted on the introduction of new molecules for the treatment of diabetes and that, since 2008, each molecule must be assessed in terms of cardiovascular risk. Because in recent years large randomized clinical trials have produced evidence of mortality reduction (both all-cause and cardiovascular mortality) with the use of GLP-1 agonists and SGLT-2 inhibitors, these results could not have been omitted in the current Guidelines. Finally, the Guidelines include some new information about the organization of medical care for patients with diabetic foot syndrome, indicating the presence of primary care and reference clinics, which is to contribute to improving the diagnosis and treatment of this complication.

Offering you this issue of Clinical Diabetology, I would like to emphasize your valuable contribution.

I look forward to further fruitful cooperation with you in creating the journal of constantly increasing scientific quality and practical value.


Prof. Janusz Gumprecht



Powiązane dokumenty

Za zasoby dyspozycyjne wód podziemnych [Rozporządzenie Ministra Środowiska z dnia 23 grudnia 2011 r. 1714) − obowiązujące od 01.01.2012 r.] uznaje się „z

Zastosowany przez autora książki zabieg interpretacyjny wydaje się być, w świetle przeprowadzonych przez niego analiz, generalnie uzasadniony; pociąga on jednak ze

Marianna, nie będąc świadoma tego, że sama jest ofiarą brutalności, będzie się jej sprzeciwiać przez całe życie, zakazując na swoich ziemiach wy- konywania kary śmierci..

Professor Janusz Gumprecht has excellently developed the journal — it appears regularly, contains more and more papers from outside Poland, is included in the Web of Science

Just before the publication of this issue of “Cli- nical Diabetology”, the largest diabetes meeting in the world — 79 th Scientific Sessions of the American Diabetes

Although more than 3,500 years have passed since the first description of the symptoms of diabetes in the Egyptian papyrus dated to around 1550 BC, diabetes is still

differences in the frequency, causes and duration of hospitalization of children with diabetes in different regions of Poland, which implies the need to ensure uniform access

Another challenge is effective and safe use of antidiabetic drugs to minimize side effects, improve adherence, increase the acceptance of the disease and reduce the risk

At the beginning of October, annual meeting of European Association for the Study of Diabetes (EASD) will be held in Berlin, and one of the most awaited events during this

Among papers included in this issue of “Clinical Diabetology”, it is worth paying attention to a multi- centre study conducted in 2013–2017 in women with type 1 diabetes who,

As the practical management of patients with diabetes should be based primarily on knowledge derived from Evidence Based Medicine (EBM), the reference to the EBM

I would like to draw your attention to the problem of diabetes care quality discussed by researchers from Libya, an interesting case report of the use of hydroxychloroquine in type

Many interesting reports presented during the Congress addressed, among others, epidemiology, new possibilities of molecular biology, measurable effects of translating basic

Following the publication of the results of already completed Cardiovascular Outcome Trials (CVOTs) on new molecules used in the treatment of diabetes, there is no doubt that

In the InTandem3 study (Study to Evaluate the Safety of So- tagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycaemic Control With Insulin Therapy Alone) with

In addition to attending the scientific meetings, I also encourage you to read the latest issue of the “Clinical Diabetology”, where, among a number of interesting articles, I would

Considering the above, I would like to draw your attention to two of many interesting articles published in the last issue of Clinical Diabetology: the paper presenting

Here, it should be mentioned that also the LEADER trial, that assessed cardiovascular safety of one of GLP-1 agonists, liraglutide, in the population of type 2 diabetes

Despite recent advances in medicine, introduction of new hypoglycaemic drugs and the fact that more than 3.500 years have passed since the earliest known record of diabetes

The conference brought together a group of distinguished lecturers and almost 500 participants — physicians dealing in their everyday practice with carbohydrate

At the same time, we intend to continue the educational function of the journal and we do not want to hinder the access to its content for the readers; therefore, we decided

This change is a result of systematic de- velopment of our journal aiming at further increasing its presence and importance on the international arena and striving to

Zum guten Verstindnis des Einflusses der Schweissung auf die Bruchgefahr muss man sich daran erinnern, dass in genieteten Schiffen al1flhige Briiche fast immer am Rande der Platte,